Ole Wichmann

9.6k total citations · 1 hit paper
217 papers, 6.5k citations indexed

About

Ole Wichmann is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Ole Wichmann has authored 217 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 84 papers in Health and 71 papers in Infectious Diseases. Recurrent topics in Ole Wichmann's work include Vaccine Coverage and Hesitancy (84 papers), Influenza Virus Research Studies (57 papers) and Respiratory viral infections research (34 papers). Ole Wichmann is often cited by papers focused on Vaccine Coverage and Hesitancy (84 papers), Influenza Virus Research Studies (57 papers) and Respiratory viral infections research (34 papers). Ole Wichmann collaborates with scholars based in Germany, Sweden and Switzerland. Ole Wichmann's co-authors include Thomas Harder, Cornelius Remschmidt, Judith Koch, Dietmar Walter, Joaquím Gascón, Gérard Krause, Jeremy Farrar, Francisco Javier Carod-Artal, Wiebke Hellenbrand and Anette Siedler and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ole Wichmann

202 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurological complications of dengue virus infection

2013 323 citations Ole Wichmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ole Wichmann Germany	41	2.7k	2.7k	2.1k	1.5k	640	217	6.5k
Helena C. Maltezou Greece	46	2.9k 1.1×	2.1k 0.8×	1.4k 0.7×	1.5k 1.0×	247 0.4×	234	6.5k
Philippe Gautret France	44	2.9k 1.1×	1.6k 0.6×	3.5k 1.6×	698 0.5×	465 0.7×	299	7.2k
Martín S. Cetron United States	44	2.4k 0.9×	3.0k 1.1×	2.8k 1.3×	378 0.3×	430 0.7×	116	7.4k
Mary E. Chamberland United States	32	2.7k 1.0×	1.4k 0.5×	1.1k 0.5×	819 0.6×	408 0.6×	64	5.0k
Natasha S. Crowcroft Canada	43	2.8k 1.0×	4.8k 1.8×	763 0.4×	1.8k 1.2×	312 0.5×	262	8.2k
Joanne M. Langley Canada	48	2.5k 0.9×	4.6k 1.7×	898 0.4×	881 0.6×	270 0.4×	237	7.9k
D. James Nokes United Kingdom	48	2.0k 0.7×	5.0k 1.8×	732 0.3×	771 0.5×	923 1.4×	208	6.9k
Brendan Flannery United States	45	1.9k 0.7×	4.5k 1.7×	619 0.3×	929 0.6×	239 0.4×	184	6.7k
Richard Pebody United Kingdom	54	3.0k 1.1×	6.9k 2.5×	736 0.3×	1.1k 0.8×	388 0.6×	297	10.0k
William J. Moss United States	45	2.2k 0.8×	3.0k 1.1×	1.5k 0.7×	1.4k 0.9×	111 0.2×	273	6.8k

Countries citing papers authored by Ole Wichmann

Since Specialization

Citations

This map shows the geographic impact of Ole Wichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Wichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Wichmann more than expected).

Fields of papers citing papers by Ole Wichmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Wichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Wichmann. The network helps show where Ole Wichmann may publish in the future.

Co-authorship network of co-authors of Ole Wichmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Wichmann. A scholar is included among the top collaborators of Ole Wichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Wichmann. Ole Wichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boccalini, Sara, Angela Bechini, Marco Del Riccio, et al.. (2025). Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeting. Human Vaccines & Immunotherapeutics. 21(1). 2451487–2451487. 1 indexed citations

Krauer, Fabienne, Marina Treskova, Mihály Koltai, et al.. (2024). Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study. BMC Medicine. 22(1). 478–478. 2 indexed citations

Schönfeld, Viktoria, et al.. (2024). Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review. Journal of Infection. 89(3). 106228–106228. 1 indexed citations

Achelrod, Dmitrij, et al.. (2023). The Role of Vaccination Centers in a National Mass Immunization Campaign—Policymaker Insights from the German COVID-19 Pandemic Vaccine Roll-Out. Vaccines. 11(10). 1552–1552.

Schönfeld, Viktoria, Anja Takla, Miriam Wiese‐Posselt, et al.. (2023). Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study. Frontiers in Public Health. 11. 1204101–1204101. 6 indexed citations

Salo, Heini, D Lévy-Brühl, Ann Lindstrand, et al.. (2023). Prices of paediatric vaccines in European vaccination programmes. Vaccine X. 15. 100392–100392. 2 indexed citations

Maier, Benjamin F., Marc Wiedermann, Frank Schlosser, et al.. (2023). Modeling the impact of the Omicron infection wave in Germany. Biology Methods and Protocols. 8(1). bpad005–bpad005. 2 indexed citations

Pilic, Antonia, Sarah Reda, Helen Burchett, et al.. (2023). Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel. Vaccine. 41(12). 1968–1978. 6 indexed citations

Kling, Kerstin, Cristina Domingo, Christian Bogdan, et al.. (2022). Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 75(12). 2266–2274. 19 indexed citations

10.

Fleischmann-Struzek, Carolin, Norman Rose, Thomas Lehmann, et al.. (2021). The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study. The European Journal of Health Economics. 23(1). 67–80. 4 indexed citations

11.

Scholz, Stefan, et al.. (2020). Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany. Value in Health. 24(1). 32–40. 10 indexed citations

12.

Klug, Stefanie J., Marianne A. B. van der Sande, Fred Zepp, et al.. (2018). Die STIKO empfiehlt die HPV-Impfung jetzt auch für Jungen. Der Urologe. 57(11). 1346–1350. 4 indexed citations

13.

Ultsch, B., Oliver Damm, Matthias Perleth, & Ole Wichmann. (2015). Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany. Value in Health. 18(7). A569–A569. 2 indexed citations

14.

Hellenbrand, Wiebke, Judith Koch, Thomas Harder, et al.. (2015). Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58(11-12). 1314–1343. 19 indexed citations

15.

Ultsch, B., Oliver Damm, Philippe Beutels, et al.. (2015). Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. 34(3). 227–244. 95 indexed citations

16.

Koch, Judith, Miriam Wiese‐Posselt, Cornelius Remschmidt, et al.. (2013). Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56(7). 957–984. 26 indexed citations

17.

Lassen, Sofie Gillesberg, Melanie Schuster, Dorothea Matysiak‐Klose, et al.. (2013). Measles outbreak spreading from the community to an anthroposophic school, Berlin, 2011. Epidemiology and Infection. 142(4). 789–796. 14 indexed citations

18.

Adlhoch, Cornelia, Marina Hoehne, Martina Littmann, et al.. (2012). Rotavirus Vaccine Effectiveness and Case-control Study on Risk Factors for Breakthrough Infections in Germany, 2010–2011. The Pediatric Infectious Disease Journal. 32(2). e82–e89. 53 indexed citations

19.

Matysiak‐Klose, Dorothea, Faruque Ahmed, Philippe Duclos, et al.. (2011). Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22–23 November 2010. Vaccine. 30(14). 2399–2404. 10 indexed citations

20.

Boven, Michiel van, Mirjam Kretzschmar, Jacco Wallinga, et al.. (2010). Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. Journal of The Royal Society Interface. 7(52). 1537–1544. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact